SC
TMO icon

Sepio Capital’s Thermo Fisher Scientific TMO Stock Holding History

Sepio Capital’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.24M Sell
4,558
-255
-5% -$138K 0.12% 106
2025
Q4 		$2.79M Buy
4,813
+789
+20% +$446K 0.15% 95
2025
Q3 		$1.95M Buy
4,024
+236
+6% +$110K 0.12% 108
2025
Q2 		$1.54M Sell
3,788
-35
-0.9% -$14.6K 0.11% 119
2025
Q1 		$1.9M Sell
3,823
-213
-5% -$115K 0.15% 107
2024
Q4 		$2.1M Buy
4,036
+130
+3% +$71.5K 0.17% 107
2024
Q3 		$2.42M Sell
3,906
-74
-2% -$43.8K 0.19% 95
2024
Q2 		$2.2M Buy
3,980
+282
+8% +$162K 0.2% 101
2024
Q1 		$2.15M Buy
3,698
+209
+6% +$117K 0.18% 109
2023
Q4 		$1.85M Buy
3,489
+565
+19% +$273K 0.16% 105
2023
Q3 		$1.48M Buy
2,924
+2,080
+246% +$1.11M 0.13% 125
2023
Q2 		$440K Buy
844
+28
+3% +$15.1K 0.04% 267
2023
Q1 		$470K Buy
816
+5
+0.6% +$2.82K 0.04% 266
2022
Q4 		$447K Buy
811
+24
+3% +$12.7K 0.04% 263
2022
Q3 		$399K Buy
787
+34
+5% +$19K 0.04% 268
2022
Q2 		$409K Buy
753
+150
+25% +$82.6K 0.04% 283
2022
Q1 		$356K Sell
603
-45
-7% -$25.9K 0.03% 295
2021
Q4 		$432K Sell
648
-8
-1% -$5K 0.03% 304
2021
Q3 		$375K Sell
656
-1,200
-65% -$659K 0.03% 301
2021
Q2 		$936K Buy
1,856
+1,219
+191% +$575K 0.08% 237
2021
Q1 		$291K Sell
637
-374
-37% -$179K 0.03% 305
2020
Q4 		$471K Sell
1,011
-368
-27% -$173K 0.04% 292
2020
Q3 		$609K Buy
1,379
+600
+77% +$248K 0.07% 235
2020
Q2 		$282K Sell
779
-4,838
-86% -$1.62M 0.03% 256
2020
Q1 		$1.59M Sell
5,617
-10,767
-66% -$3.4M 0.21% 97
2019
Q4 		$5.32M Buy
16,384
+627
+4% +$190K 0.5% 66
2019
Q3 		$4.59M Buy
15,757
+9,258
+142% +$2.65M 0.47% 71
2019
Q2 		$1.91M Buy
6,499
+309
+5% +$85.1K 0.26% 97
2019
Q1 		$1.69M Sell
6,190
-13,584
-69% -$3.38M 0.23% 106
2018
Q4 		$4.42M Buy
+19,774
New +$4.64M 0.32% 52

Other funds holding TMO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Sepio Capital's TMO Position: Q1 2026 in Review

Sepio Capital reduced its Thermo Fisher Scientific (TMO) stake by 5.3% in Q1 2026, selling an estimated $138K and leaving 4,558 shares worth $2.24M. The position accounts for 0.12% of the portfolio, ranked #106.

Sepio Capital first reported a position in TMO in Q4 2018 and has held it in 30 quarters since. The position peaked at $5.32M in Q4 2019. 2,587 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

  • Sepio Capital held 4,558 shares of Thermo Fisher Scientific worth $2.24M as of Q1 2026.
  • Sepio Capital sold 255 Thermo Fisher Scientific shares in Q1 2026, an estimated $138K.
  • Thermo Fisher Scientific made up 0.12% of Sepio Capital's portfolio in Q1 2026, its #106 holding.
  • Sepio Capital first reported a position in Thermo Fisher Scientific in Q4 2018 and has held it in 30 quarters since.
  • Sepio Capital's Thermo Fisher Scientific position peaked at $5.32M in Q4 2019.
  • 2,587 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Sepio Capital's 13F filing for Q1 2026, filed 13 May 2026.